Follicum files international patent application conferring extended protection for the topical formulation of FOL-005 and other peptides
Follicum AB ("Follicum" or the "company") announces that the company has filed an international patent application (PCT) covering the formulation of FOL-005 developed by the company. The patent application is based on new experimental data that supports the use of the formulation for peptides other than FOL-005. The formulation of FOL-005 intended for topical application on the skin has been shown to provide good hair-stimulating effect in an animal model and has been tested in alopecia patients since the beginning of the year in a phase II clinical study in Germany. If the patent application